11.07.2015 Views

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage47DateAugust 1, 201342. Insulin Pens, Pre-filledPrior authorization is required for pre-filled insulin pens. Prior authorization isgranted when documentation indicates:♦ The member’s visual or motor skills are impaired to such that the membercannot accurately draw up the insulin, and♦ There is no caregiver available to provide assistance.Prior authorization for nonpreferred insulin pens will be granted only forcases in which there is documentation <strong>of</strong> previous trial and therapy failurewith a preferred agent.Use form 470-4111, Request for Prior Authorization: Insulin, Pre-Filled Pens,to request prior authorization. Click here to see a sample <strong>of</strong> the form.43. Isotretinoin (Oral)Prior authorization is required for oral isotretinoin therapy. Payment will beapproved for preferred oral isotretinoin products for acne under the followingconditions:♦ There are documented trials and therapy failures <strong>of</strong> systemic antibiotictherapy and topical tretinoin therapy. Trials and failures <strong>of</strong> systemicantibiotic therapy and topical tretinoin therapy are not required forapproval for treatment <strong>of</strong> acne conglobata.♦ Patients and providers must be registered in, and meet all requirements<strong>of</strong>, the iPLEDGE (https://www.ipledgeprogram.com/) risk managementprogram.Payment for nonpreferred oral isotretinoin products will be authorized only forcases in which there is documentation <strong>of</strong> trials and therapy failure with apreferred agent. Initial authorization will be granted for up to 20 weeks. Aminimum <strong>of</strong> two months without therapy is required to consider subsequentauthorizations.Use form 470-4101, Request for Prior Authorization: Isotretinoin (Oral), torequest prior authorization. Click here to see a sample <strong>of</strong> the form.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!